18.38 (-%)
As of Nov 22, 2024
Source:
Exicure, Inc. have been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.
| Country | United States |
| Headquarters | chicago, illinois |
| Phone Number | 847-673-1700 |
| Industry | manufacturing |
| CEO | Paul Kang |
| Website | www.exicuretx.com |